Group 1 - The Hong Kong IPO market has shown strong momentum in the first three quarters of 2025, benefiting from global investors' interest in Chinese technology companies, making Hong Kong a preferred listing destination for AI enterprises [1] - An event titled "Mosu Acceleration Camp | Decoding the Path to Listing in Hong Kong" was held to help companies understand the listing rules, processes, and opportunities in the Hong Kong Stock Exchange, featuring participation from leading institutions like CITIC Securities and Jingtian Gongcheng Law Firm [1][3] - Key speakers at the event included KPMG partners who discussed the advantages of the Hong Kong capital market and its role as a connection between international finance and the mainland capital market, highlighting the impact of new listing regulations on technology companies [3] Group 2 - The event facilitated discussions among numerous AI companies' founders, CFOs, and investors, allowing them to engage directly with experts on their specific concerns regarding the Hong Kong listing process [3] - Future collaborations aim to empower AI enterprises through professional services and insights in capital markets and overseas development, sharing expertise to support the growth of businesses and entrepreneurs [7]

Group 1: Stock Buybacks in Hong Kong - Hong Kong companies have repurchased shares worth approximately 1544.15 billion HKD, with 247 companies buying back a total of 67.69 million shares as of November 25 [1] - In November alone, 90 companies repurchased shares totaling around 83.33 million HKD, with a concentration in sectors such as finance, information technology, consumer goods, healthcare, and energy [1] - The trend of stock buybacks is expected to continue into 2025, with leading companies demonstrating confidence in their valuations and contributing to market stability [1] Group 2: New Listings on Hong Kong Stock Exchange - Newguodu (SZ300130) has submitted its prospectus to the Hong Kong Stock Exchange, aiming to expand its financing channels and enhance its competitiveness in the global payment sector [2] - Olin Bio (SH688319) has also filed for a listing on the Hong Kong Stock Exchange, focusing on innovative vaccines, particularly in the areas of "super bacteria vaccines" and "adult vaccines" [3] - Zhongjian Technology (SZ002779) has applied for a listing on the Hong Kong Stock Exchange, seeking to leverage the capital market to expand its business in outdoor power equipment [4] Group 3: Hong Kong Stock Market Performance - The Hang Seng Index closed at 25928.08, with a slight increase of 0.13% on November 26 [5] - The Hang Seng Tech Index reached 5618.36, reflecting a gain of 0.11% [5] - The National Enterprises Index stood at 9162.37, showing a modest rise of 0.04% [5]

Core Insights - The report discusses the new paradigm of Hong Kong's capital markets driven by technological empowerment and institutional innovation, focusing on the trends and regulations for mainland companies planning to list in Hong Kong by 2025 [1][24]. Listing Pathways - The report highlights the suitability of H-share direct listings and red-chip indirect listings, with a trend towards A-share to H-share conversions. It emphasizes the importance of compliance issues related to VIE structure dismantling, H-share "full circulation," and offshore trust applications [2][18]. - The new regulatory framework established in 2023 has simplified the H-share listing process and optimized the "full circulation" mechanism, providing a more efficient cross-border financing path for large state-owned and mature private enterprises [18][24]. Practical Issues - The report identifies key legal issues for companies planning to list in Hong Kong, including the design of equity incentives, tax planning, and information disclosure, which are critical for executives to manage effectively [2][20]. - The Hong Kong Stock Exchange has introduced initiatives like the "Tech Company Fast Track" to enhance the attractiveness of the market for technology firms, aiming to facilitate their listing processes [2][10]. Hot Industries - The report categorizes key industries such as hard technology, biomedicine, and new consumption, each facing unique compliance challenges. Hard tech companies must navigate intellectual property and export control issues, while biomedicine firms focus on data security and human genetic resource protection [2][22]. - New consumption enterprises face multiple compliance tests, including third-party payment regulations and store licensing management, while domestic chain enterprises must pay attention to franchise compliance and fund management [2][22]. Market Dynamics - By 2025, Hong Kong's capital market is projected to regain its position as the world's top fundraising destination, with over 90% of the companies being from mainland China, driven by institutional innovations that facilitate access to global capital [1][24]. - The report emphasizes that the new regulatory environment and the establishment of a comprehensive filing system mark a significant shift in the cross-border listing landscape, enhancing the market's appeal for innovative enterprises [24].

Core Insights - The report "2025 Hong Kong Listing 2.0" focuses on the comprehensive filing system and analyzes the institutional innovations, practical points, and compliance requirements of the Hong Kong capital market, providing a full-process guide for domestic companies seeking to list in Hong Kong [1][2]. Group 1: Advantages of Hong Kong Capital Market - Hong Kong capital market has become a core choice for mainland companies due to its policy synergy, efficient financing, and international resource allocation advantages [1][2]. - In the first half of 2025, Hong Kong's fundraising amount returned to the global top, with over 90% of listed companies coming from mainland China [1][20]. - The Hong Kong Stock Exchange (HKEX) has introduced specialized listing channels for technology companies, including Chapter 18C and a "Tech Company Fast Track," optimizing the listing process for companies with a market value exceeding HKD 10 billion [1][2]. Group 2: Listing Pathways and Practical Operations - Companies can choose between direct H-share listings or indirect red-chip (including VIE) listings, with the filing system enhancing liquidity through "full circulation" of H-shares [1][2]. - Compliance with equity structure and special shareholder rights is crucial, especially for VIE structure companies, which may have to meet specific regulatory requirements [1][2]. - Data compliance has become a key focus in the review process, covering the entire lifecycle of data collection, storage, and cross-border transmission [1][2]. Group 3: Compliance Requirements by Industry - Hard technology companies need to pay attention to the requirements for qualified investors, core technology ownership, and export control risks [2]. - Biopharmaceutical companies must address compliance with clinical trial data, human genetic resource protection, and cross-border data transmission requirements [2]. - New consumption and chain enterprises should resolve issues related to third-party payments, store fire safety, licensing compliance, and consumer rights protection [2]. Group 4: Future Outlook and Strategic Recommendations - The report emphasizes the need for companies to establish a comprehensive compliance system throughout the listing process, focusing on equity, data, and intellectual property compliance [2]. - Hong Kong's capital market will continue to adapt to the needs of new economy enterprises through institutional innovations, further deepening its linkage with the mainland market [2][20]. - Companies are encouraged to seize policy opportunities and achieve cross-border capital operations and international development through compliance [2][20].

Core Viewpoint - The article discusses the recent trends and opportunities in the Hong Kong IPO market, highlighting the significant increase in IPO financing and the favorable conditions for companies considering listing in Hong Kong [3][4][5]. Group 1: Hong Kong IPO Market Performance - In 2023, Hong Kong's IPO financing exceeded 30 billion USD, with over 80 companies listed [4][5]. - The Hang Seng Index and Hang Seng Tech Index are expected to see substantial increases by 2025, although current valuations remain relatively low [4]. - The average daily trading volume in the Hong Kong market has nearly doubled, reaching approximately 130 billion HKD [4]. Group 2: Reasons for Companies to List in Hong Kong - Companies are increasingly choosing to list in Hong Kong as a step towards internationalization, allowing access to global capital and enhancing brand recognition [5]. - The Hong Kong Stock Exchange (HKEX) has introduced various rules, such as the 18A and 18C regulations, to accommodate companies at different stages, including those without commercial revenue [5][6]. Group 3: IPO Trends and Investor Participation - The top ten IPOs in Hong Kong accounted for over two-thirds of the total financing, indicating the importance of large projects in the market [8]. - The average first-day gain for IPOs was 38%, with a decrease in the IPO break-even rate from 34% last year to 23% this year [8][9]. - Over 85% of new IPOs included cornerstone investors, with a significant increase in the amount raised from these investors compared to the previous year [9]. Group 4: Challenges and Future Outlook - The article notes that while the market shows promise, it still faces uncertainties related to geopolitical factors and company valuations [9]. - The biopharmaceutical sector is highlighted as particularly capital-intensive, with the average cost to develop a new drug exceeding 2 billion USD [11]. - The HKEX's new measures are expected to facilitate the listing process for A-share companies, potentially increasing the number of firms opting for secondary listings in Hong Kong [6][12]. Group 5: Regulatory and Structural Considerations - The process for companies to list in Hong Kong typically involves either H-share or red-chip structures, with the latter requiring more complex arrangements [14]. - The China Securities Regulatory Commission (CSRC) has implemented a new overseas listing filing management system, which emphasizes legal compliance and data security [15][16]. - The average time for H-share projects to complete the CSRC filing is around 146 days, while more complex structures like VIE can take up to 287 days [16].

Group 1 - The 2025 Yunnan-Hong Kong-Macao Entrepreneurs Forum opened in Kunming, focusing on exploring cooperation opportunities with ASEAN in sectors such as cultural tourism, healthcare, biomedicine, and highland specialty agriculture [1] - Yunnan has a close economic relationship with the Guangdong-Hong Kong-Macao Greater Bay Area, serving as a major supplier of agricultural products and flowers, with 70% of the flowers in the Bay Area sourced from Yunnan [1] - Entrepreneurs from Yunnan, Hong Kong, and Macao are looking towards the large market of South and Southeast Asia, which has a population of 2.5 billion, to leverage their respective advantages for mutual development [1] Group 2 - As of the end of 2024, 101 overseas enterprises from Yunnan have been established in Hong Kong, with several Yunnan companies listed there [2] - The Hong Kong government has initiated a program to assist mainland enterprises in expanding internationally, highlighted by dialogue sessions on "going global" and "listing in Hong Kong" during the forum [2] - Kunming Longjin Pharmaceutical Co., Ltd. is actively exploring opportunities in ASEAN, particularly in the cultivation and research of traditional Chinese medicine, and aims to collaborate with Hong Kong and Macao institutions for project implementation [2]

随着港股市场回暖，近年来，越来越多的内地企业选择香港作为其国际化的第一站，迈瑞医疗、美的集 团等大型企业相继在港股上市，赴港IPO再掀热潮。作为本次课程的"重头戏"，招银国际王冠老师和招 商银行贾素红老师分别分享了香港上市规则与流程以及跨境IPO服务方案、海问律所的陈敏老师和徐启 飞老师分享了赴港上市中国法律以及香港法律问题及解决方案、怀新投资赵小成老师分享了港股上市过 程中媒体关系管理要点。另外，毕马威关玉锋老师、冯炜老师分别就赴港上市的财务和税务问题和与会 企业做了精彩分享。最后，香港公司治理公会北京代表处首席代表高伟博士主持的圆桌论坛上，参会嘉 宾各方围绕晋港协同发展和赴港上市的核心问题及难点，就如何进一步加强两地资本市场互联互通、助 力更多优质企业利用港交所平台走向国际等议题展开了热烈讨论。（燕云） 11月21日，由山西省金融办、山西省商务厅指导，证券时报社联合香港公司治理公会、山西省上市公司 协会、招商银行太原分行等相关单位，在山西太原举办了晋港资本市场融合发展暨香港IPO辅导公开 课，吸引了70余家企业，共计100余人参会。 本次课程汇集了深港两地资本市场的政府职能部门，券商投行、投资咨询机构、会 ...

Core Viewpoint - The recent surge in A-share companies planning to list in Hong Kong reflects a growing trend supported by favorable policies and the desire for international expansion [2][3][5]. Group 1: Company Listings - On November 19, Dashiang Group Co., Ltd. announced its plan to issue H-shares and list on the Hong Kong Stock Exchange, marking another addition to the 141 A-share companies that have proposed similar plans this year [1][2]. - As of November 19, 15 companies have expressed intentions to list in Hong Kong just in November alone, indicating a significant increase in interest [2]. Group 2: Policy Support - The surge in listings is attributed to supportive policies from both mainland and Hong Kong regulatory bodies, including a streamlined approval process for companies with a market capitalization of at least HKD 10 billion [2][4]. - The China Securities Regulatory Commission announced measures in April 2024 to support leading domestic companies in their Hong Kong listings, further enhancing the appeal of the market [2]. Group 3: Strategic Importance - Companies view listing in Hong Kong as a crucial step for internationalization and enhancing their global influence, with firms like Dajin Heavy Industry citing the need to solidify their global strategy and improve competitiveness [4][5]. - The characteristics of companies pursuing Hong Kong listings often include being industry leaders or possessing technological barriers, aiming to leverage international capital for expansion and risk diversification [4][5]. Group 4: Market Impact - The increase in A-share companies listing in Hong Kong is expected to enhance market quality and international competitiveness, promoting better connectivity between A-share and global markets [7]. - The influx of quality H-shares is likely to attract international capital and enhance the appeal of the Hong Kong market, reinforcing its status as an international financial center [7].

Core Insights - The event "Going Public in Hong Kong, Winning the Future" was successfully held, focusing on the core needs of companies going public in Hong Kong, attracting 28 company representatives from various cutting-edge sectors such as artificial intelligence, biomedicine, and intelligent manufacturing [1][4] Group 1: Legal and Compliance Aspects - Wei Haitao, a partner at Zhong Lun Law Firm, highlighted the legal practicalities of going public in Hong Kong, comparing the differences in review, independence, and compliance between Hong Kong and A-share markets, and emphasized the legal risks and opportunities [3] - The discussion included key regulatory requirements such as equity compliance, interest transmission, industry supervision, and sanction compliance during the preparation and application stages for Hong Kong listings [3] Group 2: Market Advantages - Zhang Jinmai from Tianfeng International Securities detailed the core advantages of the Hong Kong capital market, noting it has become the preferred choice for Chinese enterprises seeking international listings, with benefits in listing time, regulatory stability, and refinancing [4] - Special listing rules for biopharmaceuticals and specialized enterprises were introduced to guide companies in seizing opportunities in the Hong Kong market [4] Group 3: Human Resources Compliance - Hu Xiaoxing from Beijing Foreign Enterprise Human Resources Service Co., Ltd. discussed compliance in human resources for companies going public in Hong Kong, covering the entire cycle of recruitment, onboarding, employment, and termination, along with relevant legal obligations [7] Group 4: Event Outcomes and Future Plans - The exchange effectively addressed the information asymmetry faced by companies looking to go public in Hong Kong by interpreting policies and breaking down practical challenges [9] - Beijing Equity Exchange (北股交) aims to continue collaborating with quality partners to launch more targeted activities that meet the needs of enterprises, facilitating connections with international capital [9] Group 5: Beijing "Specialized, Refined, Characteristic, and Innovative" Board - The Beijing "Specialized, Refined, Characteristic, and Innovative" board was officially launched on August 24, 2023, providing comprehensive financial services for high-quality small and medium-sized enterprises in Beijing [10] - As of October 31, 2025, the board has 974 companies, with 185 national-level "little giant" enterprises, and has facilitated over 40 billion yuan in financing [10]

公告显示，此次H股发行旨在深化海外业务战略、强化品牌竞争力，目前公司已启动与中介机构的细节磋商， 但具体发行方案尚未最终确定。 聚和材料在公告中指出，赴港上市将依托国际资本市场优化资本结构、拓展融资渠道，进而全面提升企业综 合实力。 从A股到A+H股，聚和材料的资本战略正在升级。不过，当前H股上市计划仍处于初步筹划阶段。 根据公告，待具体方案确定后，本次H股上市尚需提交公司董事会和股东会审议，并需获得中国证监会、香港 联交所和香港证监会的批准、核准或备案。 聚和材料特别强调，本次H股上市不会导致公司控股股东和实际控制人发生变化，这有助于维持公司治理结构 的稳定性。 编辑：崔琬麟 ...